Lung Cancer

Study reveals why lung cancer patients don’t receive guideline recommended therapy

Most patients with lung cancer are receiving guideline-concordant treatment (GCT) but there is still plenty of room for improvement, a Victorian study has shown. Using data from almost 5,000 patients with NSCLC or SCLC recruited to the Victorian Lung Cancer Registry between 2011 and 2018, the study found 60.36% of patients received guideline-concordant treatment. Patterns ...

Already a member?

Login to keep reading.

© 2022 the limbic